All AbbVie's CEO wanted for Christmas was Cerevel—oh, and ImmunoGen, too

AbbVie's CEO Richard Gonzalez wanted one thing and one thing only for Christmas: Cerevel Therapeutics wrapped up quickly and neatly under his Christmas tree.

After months of negotiations, he got his wish for $8.7 billion, according to Securities and Exchange Commission (SEC) documents filed January 5.